JP4707235B2 - Ｔｉａｍ２（ｔ細胞のリンパ腫の侵襲およびｍｅｔａｓｔａｓｉｓ２）ヌクレオチド交換因子 - Google Patents

Ｔｉａｍ２（ｔ細胞のリンパ腫の侵襲およびｍｅｔａｓｔａｓｉｓ２）ヌクレオチド交換因子 Download PDF

Info

Publication number
JP4707235B2
JP4707235B2 JP2000592315A JP2000592315A JP4707235B2 JP 4707235 B2 JP4707235 B2 JP 4707235B2 JP 2000592315 A JP2000592315 A JP 2000592315A JP 2000592315 A JP2000592315 A JP 2000592315A JP 4707235 B2 JP4707235 B2 JP 4707235B2
Authority
JP
Japan
Prior art keywords
seq
tiam2
polypeptide
amino acids
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000592315A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002538774A (ja
JP2002538774A5 (enExample
Inventor
デイビッド ドゥール，
Original Assignee
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド filed Critical ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド
Publication of JP2002538774A publication Critical patent/JP2002538774A/ja
Publication of JP2002538774A5 publication Critical patent/JP2002538774A5/ja
Application granted granted Critical
Publication of JP4707235B2 publication Critical patent/JP4707235B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
JP2000592315A 1999-01-06 2000-01-06 Ｔｉａｍ２（ｔ細胞のリンパ腫の侵襲およびｍｅｔａｓｔａｓｉｓ２）ヌクレオチド交換因子 Expired - Fee Related JP4707235B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22727899A 1999-01-06 1999-01-06
US09/227,278 1999-01-06
PCT/US2000/000459 WO2000040607A2 (en) 1999-01-06 2000-01-06 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2010117840A Division JP2010233574A (ja) 1999-01-06 2010-05-21 Ｔｉａｍ２（ｔ細胞のリンパ腫の侵襲およびｍｅｔａｓｔａｓｉｓ２）ヌクレオチド交換因子
JP2011020242A Division JP2011083295A (ja) 1999-01-06 2011-02-01 Ｔｉａｍ２（ｔ細胞のリンパ腫の侵襲および転移２）ヌクレオチド交換因子

Publications (3)

Publication Number Publication Date
JP2002538774A JP2002538774A (ja) 2002-11-19
JP2002538774A5 JP2002538774A5 (enExample) 2011-03-24
JP4707235B2 true JP4707235B2 (ja) 2011-06-22

Family

ID=22852486

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000592315A Expired - Fee Related JP4707235B2 (ja) 1999-01-06 2000-01-06 Ｔｉａｍ２（ｔ細胞のリンパ腫の侵襲およびｍｅｔａｓｔａｓｉｓ２）ヌクレオチド交換因子
JP2010117840A Withdrawn JP2010233574A (ja) 1999-01-06 2010-05-21 Ｔｉａｍ２（ｔ細胞のリンパ腫の侵襲およびｍｅｔａｓｔａｓｉｓ２）ヌクレオチド交換因子
JP2011020242A Withdrawn JP2011083295A (ja) 1999-01-06 2011-02-01 Ｔｉａｍ２（ｔ細胞のリンパ腫の侵襲および転移２）ヌクレオチド交換因子

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2010117840A Withdrawn JP2010233574A (ja) 1999-01-06 2010-05-21 Ｔｉａｍ２（ｔ細胞のリンパ腫の侵襲およびｍｅｔａｓｔａｓｉｓ２）ヌクレオチド交換因子
JP2011020242A Withdrawn JP2011083295A (ja) 1999-01-06 2011-02-01 Ｔｉａｍ２（ｔ細胞のリンパ腫の侵襲および転移２）ヌクレオチド交換因子

Country Status (4)

Country Link
EP (1) EP1144448A3 (enExample)
JP (3) JP4707235B2 (enExample)
AU (1) AU2409700A (enExample)
WO (1) WO2000040607A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002026817A2 (en) * 2000-09-25 2002-04-04 Millennium Pharmaceuticals, Inc. 33521, a human guanine nucleotide exchange family member and uses thereof
EP1752040A1 (en) * 2005-08-12 2007-02-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Isolation of the t-complex distorters and applications thereof
US8679760B2 (en) * 2011-05-03 2014-03-25 National Cheng Kung University Biomarker and method for evaluating risk of proliferation, invasion, or metastasis of cancer
JP6675287B2 (ja) 2016-08-23 2020-04-01 日機装株式会社 流体殺菌装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2331441T3 (es) * 1996-06-05 2010-01-04 Novartis Vaccines And Diagnostics, Inc. Dna que codifica dp-75 y un proceso para su uso.

Also Published As

Publication number Publication date
JP2010233574A (ja) 2010-10-21
AU2409700A (en) 2000-07-24
JP2002538774A (ja) 2002-11-19
WO2000040607A3 (en) 2001-11-01
WO2000040607A2 (en) 2000-07-13
EP1144448A3 (en) 2002-03-06
JP2011083295A (ja) 2011-04-28
EP1144448A2 (en) 2001-10-17

Similar Documents

Publication Publication Date Title
JP2007289186A (ja) Ｄｐ７５をコードするｄｎａおよびその使用のための工程
CA2292339A1 (en) Smad6 and uses thereof
US7329741B2 (en) Polynucleotides that hybridize to DP-75 and their use
JP2011083295A (ja) Ｔｉａｍ２（ｔ細胞のリンパ腫の侵襲および転移２）ヌクレオチド交換因子
JPH10150993A (ja) 新規ｇ−蛋白結合受容体ｈｌｔｅｘ１１
JP2003510078A (ja) Ｍａｃａｃａｆａｓｃｉｃｕｌａｒｉｓ由来のＰ−糖タンパク質およびその使用
JPH1175874A (ja) 新規化合物
JPH11506921A (ja) ヒトｇ−タンパク質受容体ｈｃｅｇｈ４５
JP2000512506A (ja) 新規化合物
JP2000125888A (ja) シアロアドヘシンファミリ―メンバ――３
JP4112976B2 (ja) Ｐｃａ２５０１遺伝子
JPH11164693A (ja) 慢性腎不全、アテローム性動脈硬化および繊維症の標的 としての新規なｓＭＡＤ３スプライス変異体
JP4147058B2 (ja) 精神分裂病診断剤
JP4280878B2 (ja) Ｍａｓｌ１遺伝子
JP4300008B2 (ja) 新規タンパク質およびそのｄｎａ
WO2003091390A2 (en) Regulation of gene expression by neuromodulators and discovery of a novel ngf-induced protein termed pincher
JP2001145493A (ja) 熱ショック蛋白質ｈｓｐ４７と相互作用する蛋白質
JP2008118989A (ja) Ｐｃａ２５０１遺伝子
JP2005151826A (ja) Ｃ１ｑｔｎｆ５の用途
JP2001025389A (ja) Ｔｓａ７００５遺伝子
JP2001078772A (ja) Ｌｕｎｘ遺伝子及び癌微小転移の検出法
WO2001055195A1 (fr) Nouveau polypeptide, proteine de type an1 humaine, et polynucleotide codant pour ce polypeptide
JP2000093177A (ja) Ｅｏｓ遺伝子
JP2003038174A (ja) ヒトアミン受容体
JP2001046072A (ja) Ａｃｅ類似遺伝子

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091225

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100323

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100330

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100521

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100623

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100922

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100930

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101022

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20101022

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101213

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20110201

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110224

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110315

LAPS Cancellation because of no payment of annual fees